GSCN Principal Investigators
Yih-Ing Hser, Ph.D.
Dr. Yih-Ing Hser is Distinguished Research Professor in the Department of Psychiatry and Behavioral Sciences at the UCLA Integrated Substance Abuse Programs and the former Director of the Center for Advancing Longitudinal Drug Abuse Research. As a trained quantitative psychologist, she has extensive experience in health services research, treatment evaluation, and long-term follow-up research, derived from her prior and ongoing research projects. She has been conducting research in the field of substance abuse and its treatment since 1980 and has extensive experience in research design and advanced statistical techniques applied to substance abuse data. Dr. Hser has published in the areas of treatment evaluation, epidemiology, natural history of drug addiction, and innovative statistical modeling development and application.
Email: YHser@mednet.ucla.edu
Larissa J. Mooney, M.D.
Larissa Mooney, M.D., is a Professor of Clinical Psychiatry and Director of the Addiction Psychiatry Division in the Department of Psychiatry and Biobehavioral Sciences at UCLA. She directs the UCLA Addiction Psychiatry Clinic and the UCLA-Veterans Affairs (VA) Addiction Psychiatry Fellowship Program, where she teaches psychiatrists being trained in the clinical management of substance use disorders (SUDs) and mental health disorders. Dr. Mooney previously served as the Section Chief for Substance Use Disorders at the Greater Los Angeles VA. She is the President of the American Academy of Addiction Psychiatry (AAAP), a Distinguished Fellow of the American Psychiatric Association (APA), and a fellow of the American Society of Addiction Medicine (ASAM). Dr. Mooney has conducted clinical research at UCLA Integrated Substance Abuse Programs (ISAP) on pharmacological and behavioral treatment interventions for SUDs and co-occurring substance use and mental health disorders. She is one of two Principal Investigators for the Greater Southern California Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN). She has NIDA funding to study functional outcomes associated with cannabis use reduction and treatment interventions for opioid use disorder and stimulant use disorder.
Email: LMooney@mednet.ucla.edu